Cholesterol study points to new drugs

10 Sep 2012

1

Insight into how our bodies make cholesterol could lead to treatments with fewer side-effects than existing drugs.

Findings by Edinburgh scientists could pave the way for alternatives to commonly prescribed treatments, known as statins. These lower harmful cholesterol levels, but can cause liver and muscle damage.

High levels of cholesterol increase the risk of heart disease but, because cholesterol is vital to ensure the body's normal function, managing levels in the blood can be difficult.

This new study suggests a more effective approach, through a natural process

Statins curb cholesterol production - a complex series of chemical reactions that take place in the liver - by blocking production at one specific point in the process.

However, this stops the entire process and prevents the production of other molecules along the way, which have a role in making cell membranes, hormones and vitamin D.

Latest articles

Tokenising the gilt: what the UK’s digital bond pilot could mean for sovereign debt

Tokenising the gilt: what the UK’s digital bond pilot could mean for sovereign debt

Italy’s Italo selects Starlink to power onboard satellite internet across fleet

Italy’s Italo selects Starlink to power onboard satellite internet across fleet

In Delhi, AI summit frenzy drives hotel suites to $33,000 a night

In Delhi, AI summit frenzy drives hotel suites to $33,000 a night

US pauses select China tech curbs amid trade thaw ahead of Trump-Xi meeting

US pauses select China tech curbs amid trade thaw ahead of Trump-Xi meeting

ByteDance’s Seedance 2.0 video AI draws attention as China eyes next breakout AI success

ByteDance’s Seedance 2.0 video AI draws attention as China eyes next breakout AI success

Trump-linked World Liberty Financial plans low-fee forex and remittance platform

Trump-linked World Liberty Financial plans low-fee forex and remittance platform

Adyen shares slide 15% as softer payment volumes temper revenue growth

Adyen shares slide 15% as softer payment volumes temper revenue growth

China eases stance as EV makers begin direct tariff talks with EU

China eases stance as EV makers begin direct tariff talks with EU

UK selects HSBC’s blockchain platform for digital gilt pilot

UK selects HSBC’s blockchain platform for digital gilt pilot